目的與范圍《病毒學(xué)雜志》是一本開放的、同行評議的雜志，它研究了病毒學(xué)的各個方面，包括對動物、植物和微生物病毒的研究。該雜志歡迎對新型診斷工具、疫苗和抗病毒治療的基礎(chǔ)研究以及臨床前和臨床研究。《病毒學(xué)雜志》的編輯政策是公布所有由同行評審員評估的研究，使其成為科學(xué)文獻的一個連貫、合理的補充，并減少對興趣水平或感知影響的重視。《病毒學(xué)雜志》將刊登有關(guān)人類、動物、植物、昆蟲、細菌和真菌病毒的文章。該雜志還將發(fā)表關(guān)于疫苗和抗病毒藥物對病毒感染的控制和預(yù)防的分子方面的文章，以及關(guān)于病毒作為基因治療載體的使用的文章，以及對其他藥物（如朊病毒）的研究。所使用的方法和技術(shù)有望涵蓋許多學(xué)科，包括分子遺傳學(xué)、分子生物學(xué)、生物化學(xué)、生物物理學(xué)、結(jié)構(gòu)生物學(xué)、細胞生物學(xué)、免疫學(xué)、形態(tài)學(xué)、遺傳學(xué)和發(fā)病機制。病毒序列政策《病毒學(xué)雜志》歡迎提交來自新病毒的實質(zhì)性序列、與人類、動物或植物的重要暴發(fā)有關(guān)的實質(zhì)性序列，或含有重要多態(tài)性的序列，例如影響耐藥性或受體結(jié)合變化的臨床相關(guān)突變，或那些通知我們指出病毒復(fù)制或疾病的基本方面，以及下一代測序數(shù)據(jù)，如病毒體。然而，該雜志通常不會考慮與以前看到的序列相同或高度相關(guān)的短序列或序列，也不會考慮只通過地理位置的定義（例如，某一區(qū)域特定菌株的第一次描述）發(fā)布新的序列，除非有一個明確的公共衛(wèi)生含義的發(fā)現(xiàn)。這樣的增量報告可以提交給我們的姐妹期刊，遺傳。物品處理費開放訪問發(fā)布并非沒有成本。因此，《病毒學(xué)雜志》對接受出版的每一篇文章征收1370英鎊/2145美元/1745歐元的文章處理費。如果提交作者的機構(gòu)是會員機構(gòu)，則物品處理費用由會員機構(gòu)承擔，無需再支付費用。但是，如果作者的機構(gòu)是支持者成員，作者應(yīng)支付折扣的文章處理費用。我們通常免除來自低收入國家的作者的費用。對于其他國家，對于資金不足的作者，可以根據(jù)具體情況給予文章處理費用豁免或折扣。作者可以在提交過程中請求豁免或折扣。有關(guān)更多詳細信息，請參閱我們的文章處理費用頁。開放存取病毒學(xué)雜志發(fā)表的所有文章在出版后立即免費永久在線訪問，無訂閱費或注冊障礙。有關(guān)開放式訪問的更多信息，請參見此處。作為病毒學(xué)期刊上發(fā)表文章的作者，您是您文章的版權(quán)所有者，并已根據(jù)Biomed Central許可協(xié)議，提前和永久授予任何第三方使用、復(fù)制或傳播您文章的權(quán)利。對于那些美國政府雇員或出于類似原因被阻止成為版權(quán)所有者的人，Biomed Central可以容納非標準版權(quán)線。如果需要更多信息，請聯(lián)系我們。

Aims and scopeVirology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.Virology Journal will feature articles on human, animal, plant, insect, bacterial, and fungal viruses. The journal will also publish articles on molecular aspects of the control and prevention of viral infections with vaccines and antiviral agents and on the use of viruses as gene therapy vectors, as well as research on other agents such as prions. The approaches and techniques used are expected to encompass many disciplines, including molecular genetics, molecular biology, biochemistry, biophysics, structural biology, cell biology, immunology, morphology, genetics and pathogenesis.Policy on viral sequencesVirology Journal welcomes the submission of substantive sequences derived from new viruses, substantive sequences associated with important outbreaks in humans, animals or plants or those that contain important polymorphisms, such as clinically relevant mutations that affect drug resistance or changes in receptor binding or those that inform us about basic aspects of virus replication or disease, as well as next generation sequencing data such as viromes. However, the journal will not normally consider short sequences or sequences which are identical or highly related to those seen previously, nor will it publish sequences that are new only by definition of geographical location (e.g. the first description of a particular strain in a certain region), unless there is a clear public health implication of this finding. Such incremental reports can be submitted to our sister journal, Hereditas.Article-processing chargesOpen access publishing is not without costs. Virology Journal therefore levies an article-processing charge of ?1370/$2145/?1745 for each article accepted for publication. If the submitting author''s institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.Open accessAll articles published by Virology Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.As authors of articles published in Virology Journal you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.